(Q33709637)

28 July 2017

title

Treatment of moderate to severe restless legs syndrome: 2-year safety and efficacy of rotigotine transdermal patch (English)

1 reference

28 July 2017

main subject

restless legs syndrome

0 references

7

Claudia Trenkwalder

0 references

Karin Stiasny-Kolster

3

Karin Stiasny-Kolster

0 references

Birgit Högl

1

Birgit Högl

1 reference

ORCID Public Data File 2021

Werner Poewe

8

Werner Poewe

1 reference

28 July 2017

2

Wolfgang H Oertel

1 reference

28 July 2017

10

Ralf Kohnen

1 reference

28 July 2017

Diego García-Borreguero

6

Diego García-Borreguero

1 reference

28 July 2017

Peter Geisler

4

1 reference

28 July 2017

Heike Beneš

5

1 reference

28 July 2017

Erwin Schollmayer

9

1 reference

28 July 2017

publication date

28 September 2010

1 reference

28 July 2017

1 reference

28 July 2017

volume

10

1 reference

28 July 2017

page(s)

86

1 reference

Treatment of restless legs syndrome: an evidence-based review and implications for clinical practice

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958158

One year open-label safety and efficacy trial with rotigotine transdermal patch in moderate to severe idiopathic restless legs syndrome

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958158

The in vitro receptor profile of rotigotine: a new agent for the treatment of Parkinson's disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958158

Augmentation as a treatment complication of restless legs syndrome: concept and management

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958158

State of the art in restless legs syndrome therapy: practice recommendations for treating restless legs syndrome

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958158

A 52-week open-label study of the long-term safety of ropinirole in patients with restless legs syndrome

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958158

Burden of restless legs syndrome on health-related quality of life

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958158

Current guidelines and standards of practice for restless legs syndrome

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958158

The restless legs syndrome

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958158

Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958158

Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958158

Long-term treatment of cancer pain with transdermal fentanyl

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958158

A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958158

Open-label study of the long-term efficacy and safety of pramipexole in patients with Restless Legs Syndrome (extension of the PRELUDE study).

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-10-86

Randomized, blind, controlled trial of transdermal rotigotine in early Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-10-86

Patch application of the dopamine agonist rotigotine to patients with moderate to advanced stages of restless legs syndrome: a double-blind, placebo-controlled pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-10-86

Efficacy of rotigotine transdermal system in severe restless legs syndrome: a randomized, double-blind, placebo-controlled, six-week dose-finding trial in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-10-86

Efficacy of rotigotine for treatment of moderate-to-severe restless legs syndrome: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-10-86

Long-term safety and efficacy of cabergoline for the treatment of idiopathic restless legs syndrome: results from an open-label 6-month clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-10-86

Cabergoline compared to levodopa in the treatment of patients with severe restless legs syndrome: results from a multi-center, randomized, active controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-10-86

Skin acceptance of transcutaneous nitroglycerin patches: a prospective study of 33 patients

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20920156

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Efficacy of pramipexole and transdermal rotigotine in advanced Parkinson's disease: a double-blind, double-dummy, randomised controlled trial

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20920156

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1471-2377-10-86

1 reference

Dimensions Publication ID

28 July 2017

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2377-10-86

9 September 2019

1 reference

28 July 2017

1 reference